ATE347616T1 - Ribonukleinsäurederivate - Google Patents

Ribonukleinsäurederivate

Info

Publication number
ATE347616T1
ATE347616T1 AT00929665T AT00929665T ATE347616T1 AT E347616 T1 ATE347616 T1 AT E347616T1 AT 00929665 T AT00929665 T AT 00929665T AT 00929665 T AT00929665 T AT 00929665T AT E347616 T1 ATE347616 T1 AT E347616T1
Authority
AT
Austria
Prior art keywords
substituent
sample
ribonuclic
acid derivatives
rna
Prior art date
Application number
AT00929665T
Other languages
English (en)
Inventor
Andrew Simon Goldsborough
Original Assignee
Cyclops Genome Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910158.6A external-priority patent/GB9910158D0/en
Priority claimed from GBGB9910154.5A external-priority patent/GB9910154D0/en
Priority claimed from GBGB9910157.8A external-priority patent/GB9910157D0/en
Priority claimed from GBGB9910156.0A external-priority patent/GB9910156D0/en
Application filed by Cyclops Genome Sciences Ltd filed Critical Cyclops Genome Sciences Ltd
Application granted granted Critical
Publication of ATE347616T1 publication Critical patent/ATE347616T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Window Of Vehicle (AREA)
  • Materials For Medical Uses (AREA)
  • Turbine Rotor Nozzle Sealing (AREA)
AT00929665T 1999-04-30 2000-05-02 Ribonukleinsäurederivate ATE347616T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9910158.6A GB9910158D0 (en) 1999-04-30 1999-04-30 Isolation of nucleic acid
GBGB9910154.5A GB9910154D0 (en) 1999-04-30 1999-04-30 Polynucleotides
GBGB9910157.8A GB9910157D0 (en) 1999-04-30 1999-04-30 Polynucleotides
GBGB9910156.0A GB9910156D0 (en) 1999-04-30 1999-04-30 Polynucleotides

Publications (1)

Publication Number Publication Date
ATE347616T1 true ATE347616T1 (de) 2006-12-15

Family

ID=27451902

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00929665T ATE347616T1 (de) 1999-04-30 2000-05-02 Ribonukleinsäurederivate
AT00929666T ATE421583T1 (de) 1999-04-30 2000-05-02 Isolierung von nukleinsäuren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00929666T ATE421583T1 (de) 1999-04-30 2000-05-02 Isolierung von nukleinsäuren

Country Status (6)

Country Link
US (4) US6794140B1 (de)
EP (2) EP1196631B1 (de)
AT (2) ATE347616T1 (de)
AU (4) AU4588000A (de)
DE (2) DE60041442D1 (de)
WO (4) WO2000066605A2 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
ATE347616T1 (de) 1999-04-30 2006-12-15 Cyclops Genome Sciences Ltd Ribonukleinsäurederivate
US6677120B2 (en) * 2001-03-30 2004-01-13 Isis Pharmaceuticals, Inc. Building blocks for the solution phase synthesis of oligonucleotides
EP3415625A1 (de) 2002-02-01 2018-12-19 Life Technologies Corporation Doppelsträngige oligonukleotide
US20060009409A1 (en) * 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
US20040072226A1 (en) * 2002-07-03 2004-04-15 Stojanovic Milan N. Movement of multi-enzymatic nanoassemblies on recognition landscapes
US20040005568A1 (en) * 2002-07-03 2004-01-08 Stojanovic Milan N. Movement of multi-enzymatic nanoassemblies on recognition landscapes
GB0217963D0 (en) 2002-08-02 2002-09-11 Cyclops Genome Sciences Ltd Purification of nucleic acids
DE10315581B4 (de) * 2003-04-05 2007-06-28 Agilent Technologies, Inc. (n.d.Ges.d.Staates Delaware), Palo Alto Verfahren zur Qualitätsbestimmung von RNA-Proben
WO2005012522A1 (en) * 2003-07-23 2005-02-10 Cyclops Genome Sciences Limited Clean-up beads
GB0317199D0 (en) * 2003-07-23 2003-08-27 Cyclops Genome Sciences Ltd Clean-up beads
DE10344819B4 (de) * 2003-09-26 2017-06-29 Sartorius Stedim Biotech Gmbh Adsorptionsmembranen, Verfahren zur Herstellung derselben und Vorrichtungen, welche die Adsorptionsmembranen umfassen
CA2586532C (en) 2004-11-05 2014-03-25 Qiagen North American Holdings, Inc. Compositions and methods for purifying nucleic acids from stabilization reagents
US20090075342A1 (en) * 2005-04-26 2009-03-19 Sharon Cload Metabolic profile directed aptamer medicinal chemistry
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US8318424B2 (en) * 2006-06-05 2012-11-27 The University Of North Carolina At Chapel Hill High-throughput RNA structure analysis
AU2008212820B2 (en) 2007-02-09 2014-01-30 Northwestern University Particles for detecting intracellular targets
WO2008119539A2 (en) * 2007-03-30 2008-10-09 Qiagen Gmbh Modified polynucleotides comprising ribose rings
AU2008259907B2 (en) 2007-05-30 2014-12-04 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
US9551033B2 (en) 2007-06-08 2017-01-24 Genentech, Inc. Gene expression markers of tumor resistance to HER2 inhibitor treatment
US7998967B2 (en) 2008-03-03 2011-08-16 Tosk, Incorporated Methotrexate adjuvants to reduce toxicity and methods for using the same
WO2009150156A1 (en) * 2008-06-13 2009-12-17 Riboxx Gmbh Method for enzymatic synthesis of chemically modified rna
DK2365803T3 (en) 2008-11-24 2018-01-22 Univ Northwestern POLYVALENT RNA NANOPARTICLE COMPOSITIONS
US20100233270A1 (en) * 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
KR102231531B1 (ko) 2009-02-13 2021-03-23 엑스-켐, 인크. Ｄｎａ―코딩된 라이브러리의 생성 및 스크리닝 방법
EP2272976A1 (de) * 2009-07-06 2011-01-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Differenzierung von Polynucleotid-Strängen
EP2473638B1 (de) 2009-09-30 2017-08-09 Natera, Inc. Verfahren zur nichtinvasiven pränatalen ploidiezuordnung
JP5866119B2 (ja) 2009-10-30 2016-02-17 ノースウェスタン ユニバーシティ 鋳型ナノ複合体
EP2333102A1 (de) * 2009-12-14 2011-06-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Identifizierung von RNA-Liganden
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US8825412B2 (en) 2010-05-18 2014-09-02 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
EP2388324A1 (de) 2010-05-20 2011-11-23 Siemens Healthcare Diagnostics Inc. Kontrollmaterial für Nukleinsäureteste
FR2968302B1 (fr) 2010-12-06 2012-11-30 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
EP2656263B1 (de) 2010-12-22 2019-11-06 Natera, Inc. Verfahren für nichtinvasiven pränatalen vaterschaftstest
JP6153874B2 (ja) 2011-02-09 2017-06-28 ナテラ， インコーポレイテッド 非侵襲的出生前倍数性呼び出しのための方法
ES2675111T3 (es) * 2011-09-07 2018-07-06 X-Chem, Inc. Métodos para etiquetar bibliotecas con codificación de ADN
JP2014526517A (ja) 2011-09-14 2014-10-06 ノースウェスタン ユニバーシティ 血液脳関門を通過することができるナノ抱合体
US9040679B2 (en) 2012-04-30 2015-05-26 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
US9044738B2 (en) 2012-04-30 2015-06-02 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9040675B2 (en) 2012-04-30 2015-05-26 General Electric Company Formulations for nucleic acid stabilization on solid substrates
CN104685115A (zh) 2012-07-13 2015-06-03 X-化学有限公司 具有聚合酶不可读的编码性寡核苷酸连接的dna编码文库
FR2994184B1 (fr) 2012-08-02 2017-12-08 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US9970002B2 (en) * 2012-12-12 2018-05-15 Massachusetts Institute Of Technology Compositions and methods for functional nucleic acid delivery
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
ES2791873T3 (es) 2013-10-07 2020-11-06 Univ North Carolina Chapel Hill Detección de modificaciones químicas en ácidos nucleicos
CN113774132A (zh) 2014-04-21 2021-12-10 纳特拉公司 检测染色体片段中的突变和倍性
JP6571679B2 (ja) 2014-04-25 2019-09-04 トランスレイト バイオ， インコーポレイテッド メッセンジャーｒｎａの精製方法
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP3209403A4 (de) * 2014-10-24 2018-09-12 Abbott Molecular Inc. Anreicherung von kleinen nukleinsäuren
US11213593B2 (en) 2014-11-21 2022-01-04 Northwestern University Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
DK3294885T3 (da) 2015-05-08 2020-08-10 Curevac Real Estate Gmbh Fremgangsmåde til at fremstille rna
DK3294906T3 (en) 2015-05-11 2024-08-05 Natera Inc Methods for determining ploidy
PL4108769T3 (pl) 2015-05-29 2024-02-05 CureVac Manufacturing GmbH Sposób wytwarzania i oczyszczania rna obejmujący co najmniej jeden etap filtracji o przepływie stycznym
SG10201911134QA (en) 2015-06-05 2020-01-30 Grace W R & Co Adsorbent bioprocessing clarification agents and methods of making and using the same
EP3754011B1 (de) 2015-09-09 2022-02-16 Drawbridge Health, Inc. Vorrichtungen zur probeentnahme, stabilisierung und konservierung
US10214739B2 (en) * 2015-10-30 2019-02-26 Axagarius Gmbh & Co. Kg RNA binding solution
DK3443119T3 (da) 2016-04-15 2022-05-23 Natera Inc Fremgangsmåde til bestemmelse af lunge cancer
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
WO2018085752A2 (en) * 2016-11-07 2018-05-11 nanoSUR LLC Post-transcriptionally chemically modified double strand rnas
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CN115251923A (zh) 2017-01-10 2022-11-01 集联健康有限公司 用于样品收集的装置、系统和方法
WO2018156418A1 (en) * 2017-02-21 2018-08-30 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
WO2018231090A1 (ru) * 2017-06-16 2018-12-20 Борис Славинович ФАРБЕР Комбинаторные производные олигонуклеотидов рнк
US11807623B2 (en) 2017-11-30 2023-11-07 Arrakis Therapeutics, Inc. Nucleic acid-binding photoprobes and uses thereof
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
WO2019161244A1 (en) 2018-02-15 2019-08-22 Natera, Inc. Methods for isolating nucleic acids with size selection
FR3078977B1 (fr) * 2018-03-16 2023-03-17 Biomerieux Sa Procede d'extraction d'acides nucleiques
DK3781714T3 (da) 2018-04-14 2026-03-30 Natera Inc Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3980559A1 (de) 2019-06-06 2022-04-13 Natera, Inc. Verfahren zur detektion von immunzellen-dna und zur überwachung des immunsystems
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
MX2024002299A (es) * 2021-08-31 2024-03-07 nanoSUR LLC Composiciones de arnbc modificado de peso molecular elevado.
US20250027084A1 (en) * 2021-11-30 2025-01-23 Northwestern University Compositions for inhibiting dipeptide repeat protein-ribosomal rna interaction and uses thereof
AU2024217803A1 (en) * 2023-02-06 2025-08-21 The Board Of Trustees Of The Leland Stanford Junior University Methods and modifications for reducing innate immune responses to rna
US20250270299A1 (en) * 2024-01-31 2025-08-28 Helix Nanotechnologies Inc Methods of using compositions comprising sbi domains

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
US5681726A (en) 1988-09-19 1997-10-28 Stratagene Method of double stranded DNA synthesis
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US5707796A (en) * 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
US5660985A (en) * 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
DE69133511T2 (de) * 1990-08-13 2006-09-28 Isis Pharmaceuticals, Inc., Carlsbad Zuckermodifizierte oligonukleotide zum erkennen und steuern der genexpression
US5426180A (en) * 1991-03-27 1995-06-20 Research Corporation Technologies, Inc. Methods of making single-stranded circular oligonucleotides
US6235887B1 (en) * 1991-11-26 2001-05-22 Isis Pharmaceuticals, Inc. Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
CN1078478C (zh) 1993-02-24 2002-01-30 王瑞駪 活性抗病毒聚合物的组成及应用方法
ES2127948T3 (es) * 1993-10-27 1999-05-01 Ribozyme Pharm Inc Oligonucleotidos modificados en la posicion 2'-amido y 2'-peptido.
US5700642A (en) * 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
EP0934330A1 (de) * 1996-07-24 1999-08-11 Michelle M. Hanna Basengeschuetzte nukleotid-analoge mit geschuetzten thiolgruppen
US5849902A (en) * 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
WO1999014346A2 (en) * 1997-09-19 1999-03-25 Sequitur, Inc. SENSE mRNA THERAPY
DE19801153A1 (de) 1998-01-14 1999-07-15 Jenne Andreas Verfahren zur Selektion von Ribozymen, die Ribonucleinsäuren in trans an 2'-OH-Gruppen kovalent modifizieren können und durch dieses Verfahren erhältliche Ribozyme
JP2002512794A (ja) 1998-04-29 2002-05-08 リボザイム・ファーマシューティカルズ・インコーポレーテッド ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込み
WO2000006605A2 (en) 1998-07-28 2000-02-10 Micromet Ag Heterominibodies
ATE347616T1 (de) 1999-04-30 2006-12-15 Cyclops Genome Sciences Ltd Ribonukleinsäurederivate
US6720144B1 (en) * 2001-06-21 2004-04-13 Quest Diagnostics Detection of clonal T-cell receptor-γ gene rearrangement by PCR/temporal temperature gradient gel electrophoresis (TTGE)
GB0217963D0 (en) * 2002-08-02 2002-09-11 Cyclops Genome Sciences Ltd Purification of nucleic acids
WO2005012522A1 (en) 2003-07-23 2005-02-10 Cyclops Genome Sciences Limited Clean-up beads

Also Published As

Publication number Publication date
WO2000066605A2 (en) 2000-11-09
ATE421583T1 (de) 2009-02-15
WO2000066605A3 (en) 2001-04-26
AU4767400A (en) 2000-12-28
US20050074753A1 (en) 2005-04-07
WO2000075306A3 (en) 2001-05-17
US6794140B1 (en) 2004-09-21
DE60041442D1 (de) 2009-03-12
AU4589000A (en) 2000-11-17
WO2000075302A3 (en) 2001-04-26
DE60032235T2 (de) 2007-11-15
EP1177281A2 (de) 2002-02-06
AU4588000A (en) 2000-12-28
US20030039985A1 (en) 2003-02-27
US7244568B2 (en) 2007-07-17
US6867290B2 (en) 2005-03-15
EP1196631A1 (de) 2002-04-17
AU4767300A (en) 2001-12-17
US20050272679A1 (en) 2005-12-08
EP1177281B1 (de) 2009-01-21
WO2000075306A2 (en) 2000-12-14
WO2001094626A1 (en) 2001-12-13
WO2000075302A2 (en) 2000-12-14
EP1196631B1 (de) 2006-12-06
DE60032235D1 (de) 2007-01-18

Similar Documents

Publication Publication Date Title
DE60032235D1 (de) Ribonukleinsäurederivate
McCORMICK et al. Identification of biotransformation products from 2, 4-dinitrotoluene
EP0731174A3 (de) Verfahren zur Amplifikation von Nukleinsäuresequenzen
CA2265477A1 (en) System for in vitro transposition using modified tn5 transposase
ATE521718T1 (de) Prozess zur synthetisierung von nukleinsäure
SE8800864D0 (sv) Method of assaying of nucleic acids, a reagent combination and kit therefore
Pfau et al. N6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen
WO2000053804A3 (en) Genetic screening
NO307710B1 (no) Fremgangsmåte ved fremstilling av <beta>-laktamer
NZ307444A (en) Polyphenol oxidase genes from lettuce and banana
WO1999051547A3 (en) Solid phase synthesis of organic compounds via phosphitylating reagents
PL348627A1 (en) Method of obtaining polyorganocilylalkylsulphanes
KR830006281A (ko) 비스글리코시일 모라노린 유도체의 제조법
KR860001108A (ko) 페닐-나프티리딘의 제조방법
Tong et al. Molecular pharmacology of the haloethyl nitrosoureas: formation of 6-hydroxyethylguanine in DNA treated with BCNU (N, N1-bis [2-chloroethyl]-N-nitrosourea)
KR840005139A (ko) 피라졸로피리딘 유도체의 제조방법
Bergeron et al. Synthesis of a parabactin photoaffinity label
EP0708767A4 (de) Haptene, tracer, immunogene und antikörper für carbazol - und dibenzofuran - derivate
AU3814800A (en) Enantiomers of mercapto lactones and processes for their synthesis
PT1030838E (pt) Metodo de sintese de pirrolamidas
JPS5523994A (en) Novel microorganism
DE60102232D1 (de) Kosteneffektive methode zur selektiven methylierung von erythromycin a-derivaten
Martínez‐Montero et al. Improved Synthesis and Isolation of 2′‐O‐Methyladenosine: Effective and Scalable Enzymatic Separation of 2′/3′‐O‐Methyladenosine Regioisomers
KR900006517A (ko) 항생제 pb-6042류
Kwon et al. New synthesis of 3′-deoxypurine nucleosides using samarium (III) iodide complex

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties